New drug combo aims to control advanced colorectal cancer
Disease control
Not yet recruiting
This study tests a new drug called AMT-676 combined with standard chemotherapy drugs in 180 people with advanced colorectal cancer that cannot be removed by surgery. The goal is to see if the combination is safe and helps control the cancer. Participants will receive the treatmen…
Phase: PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 05:48 UTC